Posted by Michael Wonder on 17 Feb 2023
Mitapivat sulphate for the treatment of patients with pyruvate kinase deficiency
16 February 2023 - NICE is unable to make a recommendation on the the use of mitapivat sulphate (Pyrukynd) for the treatment of adults with pyruvate kinase deficiency because Agios Pharmaceuticals did not provide an evidence submission.
NICE will review this decision if Agios Pharmaceuticals decides to make a submission.
